BioCentury | Nov 21, 2011
Clinical News

Regenocytes pulmonary data

...tests and the patient has had no infections or hospitalizations at about 8 months post-treatment. Regenocyte Therapeutic...
BioCentury | Feb 8, 2010
Clinical News

Regenocytes cardiovascular data

...at 6 months post-treatment from 23% at baseline. Ejection fraction at 3 months was 38%. Regenocyte Therapeutic...
BioCentury | Dec 7, 2009
Clinical News

Regenocytes cardiovascular data

...his heart increased ejection fraction to 52% at one year post-treatment from 20% at baseline. Regenocyte Therapeutic...
BioCentury | Nov 23, 2009
Clinical News

Regenocytes cardiovascular data

...his heart increased ejection fraction to 44% at 6 months post-treatment from 25% at baseline. Regenocyte Therapeutic...
BioCentury | Jun 29, 2009
Clinical News

Regenocytes cardiovascular data

...treatment was 51%, up from 18% at baseline. Ejection fraction at 3 months was 40%. Regenocyte...
...Co. Ltd. (Tel Aviv, Israel) and the American Institute for Regenerative Medicine (Santiago, Dominican Republic). Regenocyte Therapeutic...
BioCentury | May 25, 2009
Clinical News

Regenocytes cardiovascular data

...patient no longer needs to be supplemented with oxygen or considered for a lung transplant. Regenocyte...
...collaboration with researchers from TheraVitae Co. Ltd. (Tel Aviv, Israel) and the Mayo Clinic . Regenocyte Therapeutic...
Items per page:
1 - 6 of 6
BioCentury | Nov 21, 2011
Clinical News

Regenocytes pulmonary data

...tests and the patient has had no infections or hospitalizations at about 8 months post-treatment. Regenocyte Therapeutic...
BioCentury | Feb 8, 2010
Clinical News

Regenocytes cardiovascular data

...at 6 months post-treatment from 23% at baseline. Ejection fraction at 3 months was 38%. Regenocyte Therapeutic...
BioCentury | Dec 7, 2009
Clinical News

Regenocytes cardiovascular data

...his heart increased ejection fraction to 52% at one year post-treatment from 20% at baseline. Regenocyte Therapeutic...
BioCentury | Nov 23, 2009
Clinical News

Regenocytes cardiovascular data

...his heart increased ejection fraction to 44% at 6 months post-treatment from 25% at baseline. Regenocyte Therapeutic...
BioCentury | Jun 29, 2009
Clinical News

Regenocytes cardiovascular data

...treatment was 51%, up from 18% at baseline. Ejection fraction at 3 months was 40%. Regenocyte...
...Co. Ltd. (Tel Aviv, Israel) and the American Institute for Regenerative Medicine (Santiago, Dominican Republic). Regenocyte Therapeutic...
BioCentury | May 25, 2009
Clinical News

Regenocytes cardiovascular data

...patient no longer needs to be supplemented with oxygen or considered for a lung transplant. Regenocyte...
...collaboration with researchers from TheraVitae Co. Ltd. (Tel Aviv, Israel) and the Mayo Clinic . Regenocyte Therapeutic...
Items per page:
1 - 6 of 6